Empagliflozin prevents doxorubicin-induced myocardial dysfunction

被引：0
|
作者：
Jolanda Sabatino
Salvatore De Rosa
Laura Tammè
Claudio Iaconetti
Sabato Sorrentino
Alberto Polimeni
Chiara Mignogna
Andrea Amorosi
Carmen Spaccarotella
Masakazu Yasuda
Ciro Indolfi
机构：
[1] Magna Graecia University,Division of Cardiology, Department of Medical and Surgical Sciences
[2] Magna Graecia University,Cardiovascular Research Center
[3] Magna Graecia University,Department of Health Sciences
[4] URT CNR of IFC,undefined
[5] Magna Graecia University,undefined
来源：
Cardiovascular Diabetology | / 19卷
关键词：
Heart failure; Cardiotoxicity; Left ventricular function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Empagliflozin prevents doxorubicin-induced myocardial dysfunction
    Sabatino, Jolanda
    De Rosa, Salvatore
    Tamme, Laura
    Iaconetti, Claudio
    Sorrentino, Sabato
    Polimeni, Alberto
    Mignogna, Chiara
    Amorosi, Andrea
    Spaccarotella, Carmen
    Yasuda, Masakazu
    Indolfi, Ciro
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01) : 66
  • [2] NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo
    Huang, Xin
    Liu, Yang
    Yang, Xiaolei
    Lai, Song
    Zhang, Yunlong
    Gu, Jie
    Li, Huihua
    Xie, Yunpeng
    Xia, Yunlong
    LIFE SCIENCES, 2019, 227 : 94 - 100
  • [3] Empagliflozin attenuates doxorubicin-induced cardiotoxicity
    Baris, Veysel Ozgur
    Dincsoy, Adnan Berk
    Gedikli, Esra
    Zirh, Selim
    Muftuoglu, Sevda
    Erdem, Aysen
    TOXICOLOGY RESEARCH, 2023, 12 (05) : 998 - 998
  • [4] Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver
    Hinkley, J. Matthew
    Morton, Aaron B.
    Ichinoseki-Sekine, Noriko
    Huertas, Andres Mor
    Smuder, Ashley J.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2019, 51 (06): : 1106 - 1115
  • [5] ABSENCE OF ACUTE DOXORUBICIN-INDUCED MYOCARDIAL MITOCHONDRIAL DYSFUNCTION
    PELIKAN, PCD
    GERSTENBLITH, G
    VANDEGAER, KM
    JACOBUS, WE
    CLINICAL RESEARCH, 1985, 33 (02): : A217 - A217
  • [6] Telomerase Reverse Transcriptase Prevents Doxorubicin-induced Microvascular Endothelial Dysfunction
    Brandt, Lukas
    Hader, Shelby
    Beyer, Andreas
    PHYSIOLOGY, 2024, 39
  • [7] Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
    Takaaki Furihata
    Satoshi Maekawa
    Shingo Takada
    Naoya Kakutani
    Hideo Nambu
    Ryosuke Shirakawa
    Takashi Yokota
    Shintaro Kinugawa
    BMC Pharmacology and Toxicology, 22
  • [8] Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
    Furihata, Takaaki
    Maekawa, Satoshi
    Takada, Shingo
    Kakutani, Naoya
    Nambu, Hideo
    Shirakawa, Ryosuke
    Yokota, Takashi
    Kinugawa, Shintaro
    BMC PHARMACOLOGY & TOXICOLOGY, 2021, 22 (01):
  • [9] Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways
    Baris, Veysel Ozgur
    Dincsoy, Adnan Berk
    Gedikli, Esra
    Zirh, Selim
    Muftuoglu, Sevda
    Erdem, Aysen
    CARDIOVASCULAR TOXICOLOGY, 2021, 21 (09) : 747 - 758
  • [10] Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways
    Veysel Özgür Barış
    Adnan Berk Dinçsoy
    Esra Gedikli
    Selim Zırh
    Sevda Müftüoğlu
    Ayşen Erdem
    Cardiovascular Toxicology, 2021, 21 : 747 - 758
12345